Brief: Aequus announces advancement of anti-nausea transdermal extended-release patent application
05/08/2016 16:00
Aug 5 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus announces advancement of Anti-Nausea Transdermal
Extended-Release patent application
Source text for Eikon: ID:nMKW08DD8a
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange